donepezil has been researched along with bisindolylmaleimide i in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sen, S; Sinha, N | 1 |
| Guo, F; Hu, Z; Wang, D; Wang, J; Wei, D; Yang, H; Yang, S | 1 |
1 trial(s) available for donepezil and bisindolylmaleimide i
| Article | Year |
|---|---|
Efficacy and safety of NAD+ ADP-ribosyltransferase 1 agonist versus Donepezil in elderly Chinese patients with Alzheimer disease: A novel target for effective therapy.
Topics: Aged; Amyloid beta-Peptides; China; Cholinesterase Inhibitors; Donepezil; Enzyme Inhibitors; Female; Humans; Indoles; Male; Maleimides | 2019 |
1 other study(ies) available for donepezil and bisindolylmaleimide i
| Article | Year |
|---|---|
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |